Inari Medical, Inc. (NARI) Appoints Robert Warner to its Board

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the appointment of Mr. Robert Warner to its board of directors. Mr. Warner will serve as a member of the Audit Committee of the board.

“We are pleased to welcome Robert as a new independent director to our board. Mr. Warner’s decades of executive operating experience, including internationally, will be highly valuable to Inari as we enter the next phase of our mission to treat and transform the lives of patients suffering from venous and other diseases,” said Bill Hoffman, Inari’s Chief Executive Officer.

You May Also Be Interested In

• XORTX board chairman Anthony Giovinazzo resigns
• NewcelX prices $1.4M private placement at 20% premium to market
• INmune Bio forms advisory board for CORDStrom cell therapy platform